Should patients undergoing broad DNA testing for a specific ailment be told of unexpected findings that signal risk of cancer or other serious diseases, even if they dont request the information?
By 2030, we will see 2.3 million new cancer cases in the United States, a 45% increase over 2010, according to the American Cancer Society. As the number of new cancer cases has increased, so too has cancer survivorship. Advances in cancer research and technology have brought life-saving breakthroughs in the fight against cancer, but the rapidly evolving science has also resulted in greater cost as patients take advantage of new diagnostic tools and procedures. Optum executives offer 6 employer strategies for managing the high cost of cancer care, based on a recent Optum white paper.
Willis North America announces the creation of its own private exchange and InsureXSolutions adds ancillary benefits to its existing product list.
The e-newsletter from Employee Benefit NewsSubscribe Read the latest issue View archives
Just-in-time voluntary benefits sales and marketing information.
The court observed that a person is a fiduciary only to the extent it exercises authority or control over plan assets in a case involving a small prosthetic limbs manufacturer and American United Life.